[U.S. DEPARTMENT OF DEFENSE - Ovarian Cancer Clinical Development Award | Research Funding]
Event details
| Date | 25.07.2018 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Ovarian Cancer Clinical Development Award. This Award will support the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life. The goal of this award mechanism is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof of concept demonstrating the potential utility of the proposed product or a prototype/ preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed. Relevant data, either published or unpublished, that support the study rationale are required.
For projects proposing clinical trials, this Award mechanism is offering an optional nested Early-Career Investigator to foster the next generation of ovarian cancer investigators in the conduct of clinical trials.
Funding: Maximum USD $600’000
Maximum USD $800’000 (w/ nested Early Career Investigator)
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Applicants at the Assistant Professor level or higher are eligible. Optional nested Early-Career investigators must be within 5 years of their last training position.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, and a letter of intent as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 25 July 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 08 August 2018, 11:59 p.m. EST (05:59 09 Aug, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-OCRP-CDA
Further information
For projects proposing clinical trials, this Award mechanism is offering an optional nested Early-Career Investigator to foster the next generation of ovarian cancer investigators in the conduct of clinical trials.
Funding: Maximum USD $600’000
Maximum USD $800’000 (w/ nested Early Career Investigator)
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Applicants at the Assistant Professor level or higher are eligible. Optional nested Early-Career investigators must be within 5 years of their last training position.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a list of collaborators and key personnel, and a letter of intent as suggested on the platform. Full applications (by invitation) will be made via a Grants.gov workspace. Full application packages can be downloaded from Grants.gov at any time.
Pre-Application Deadline: 25 July 2018, 5:00 p.m. EST (23:00 CET)
Full Application Deadline: 08 August 2018, 11:59 p.m. EST (05:59 09 Aug, CET)
Grants.gov Funding Opportunity Number: W81XWH-18-OCRP-CDA
Further information
- To see the program announcement, navigate to the search page on Grants.gov and search for the Opportunity Number W81XWH-18-OCRP-CDA
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
Practical information
- General public
- Free